Compare BLCO & SSRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | SSRM |
|---|---|---|
| Founded | 1853 | 1946 |
| Country | Canada | United States |
| Employees | N/A | 2900 |
| Industry | Ophthalmic Goods | Precious Metals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.5B |
| IPO Year | 2022 | N/A |
| Metric | BLCO | SSRM |
|---|---|---|
| Price | $17.10 | $30.00 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 4 |
| Target Price | $18.55 | ★ $26.74 |
| AVG Volume (30 Days) | 454.5K | ★ 4.3M |
| Earning Date | 05-21-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,101,000,000.00 | N/A |
| Revenue This Year | $8.61 | $58.93 |
| Revenue Next Year | $5.52 | $6.60 |
| P/E Ratio | ★ N/A | $14.37 |
| Revenue Growth | ★ 6.47 | N/A |
| 52 Week Low | $10.45 | $8.65 |
| 52 Week High | $18.92 | $33.49 |
| Indicator | BLCO | SSRM |
|---|---|---|
| Relative Strength Index (RSI) | 44.68 | 56.01 |
| Support Level | $16.35 | $21.57 |
| Resistance Level | $17.44 | N/A |
| Average True Range (ATR) | 0.59 | 1.99 |
| MACD | -0.12 | -0.08 |
| Stochastic Oscillator | 36.40 | 64.49 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.